Mitopure® Powder

Timeline's Mitopure Powder delivers the same 500 mg dose of the company's patented, purified urolithin A used in its better-known softgel product, and, unlike many single-ingredient supplement reformulations, the powder itself was the actual dosing vehicle in the Singh 2022 'NOURISH' pharmacokinetic trial that established urolithin A's 6-fold bioavailability advantage over dietary pomegranate juice, giving this specific format its own direct human plasma data rather than relying purely on inference from the softgel. That said, the flagship muscle-strength and endurance trials most often cited in Timeline's marketing (Andreux 2019, Singh/Liu 2022) do not clearly document which oral formulation was administered, so full efficacy equivalence across all of Timeline's Mitopure formats is not yet formally confirmed pending an unreported five-formulation head-to-head PK study (NCT06362018). Buyers should also note this pure berry-flavored powder is a distinct SKU from Timeline's separate whey-protein 'Mitopure + Protein' shake, and that at $125 for a 30-day supply (as low as $85/month on a 12-month subscription), it sits at the high end of the urolithin A category, a price that an independent lab test suggests is at least backed by accurate labeling, since the product tested above its stated dose while most competing urolithin A supplements did not.